193 related articles for article (PubMed ID: 26975668)
21. Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.
Singla N; Haddad AQ; Passoni NM; Meissner M; Lotan Y
World J Urol; 2017 Jan; 35(1):105-111. PubMed ID: 27194044
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds.
Sinha R; El-Bayoumy K
Curr Cancer Drug Targets; 2004 Feb; 4(1):13-28. PubMed ID: 14965264
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention for gastric cancer.
Ford AC
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):581-92. PubMed ID: 22122773
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of breast cancer.
Castrellon AB; Glück S
Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
[TBL] [Abstract][Full Text] [Related]
25. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
26. [Development of bladder cancer chemoprevention].
Dai G; Wang X
Wei Sheng Yan Jiu; 2003 Mar; 32(2):159-62. PubMed ID: 12793013
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.
Knapp DW; Glickman NW; Mohammed SI; DeNicola DB; Widmer WR; Bonney PL; DeGortari AE
Adv Exp Med Biol; 2002; 507():377-80. PubMed ID: 12664613
[No Abstract] [Full Text] [Related]
28. Melanoma Chemoprevention: Current Status and Future Prospects.
Chhabra G; Ndiaye MA; Garcia-Peterson LM; Ahmad N
Photochem Photobiol; 2017 Jul; 93(4):975-989. PubMed ID: 28295364
[TBL] [Abstract][Full Text] [Related]
29. Use of selenium in chemoprevention of bladder cancer.
Brinkman M; Buntinx F; Muls E; Zeegers MP
Lancet Oncol; 2006 Sep; 7(9):766-74. PubMed ID: 16945772
[TBL] [Abstract][Full Text] [Related]
30. Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
Grossman HB; Stenzl A; Moyad MA; Droller MJ
Scand J Urol Nephrol Suppl; 2008 Sep; (218):213-33. PubMed ID: 18815935
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of bladder cancer.
Golijanin DJ; Kakiashvili D; Madeb RR; Messing EM; Lerner SP
World J Urol; 2006 Nov; 24(5):445-72. PubMed ID: 17048030
[No Abstract] [Full Text] [Related]
32. Selenium Compounds as Novel Potential Anticancer Agents.
Radomska D; Czarnomysy R; Radomski D; Bielawski K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498364
[TBL] [Abstract][Full Text] [Related]
33. Primary and Secondary Chemoprevention of Malignant Melanoma.
Mounessa J; Buntinx-Krieg T; Qin R; Dunnick CA; Dellavalle RP
Am J Clin Dermatol; 2016 Dec; 17(6):625-634. PubMed ID: 27665299
[TBL] [Abstract][Full Text] [Related]
34. Prevention strategies for prostate cancer.
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C
Minerva Urol Nefrol; 2012 Dec; 64(4):225-31. PubMed ID: 23288209
[TBL] [Abstract][Full Text] [Related]
35. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.
Gronich N; Rennert G
Nat Rev Clin Oncol; 2013 Nov; 10(11):625-42. PubMed ID: 24080598
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of bladder cancer.
Malone WF; Kelloff GJ; Pierson H; Greenwald P
Cancer; 1987 Aug; 60(3 Suppl):650-7. PubMed ID: 3297290
[TBL] [Abstract][Full Text] [Related]
37. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
38. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
39. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer.
Amin S; Boffetta P; Lucas AL
Gut Liver; 2016 Sep; 10(5):665-71. PubMed ID: 27563018
[TBL] [Abstract][Full Text] [Related]
40. Atorvastatin: a potential chemopreventive agent in bladder cancer.
Kamat AM; Nelkin GM
Urology; 2005 Dec; 66(6):1209-12. PubMed ID: 16360444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
